Educational research on US and Indian equities, ETFs, mutual funds and crypto, with screeners and a free investing academy.
All data is for educational purposes only and should not be considered investment advice.
Equiscale is operated by Syntellia LLC, a Delaware limited liability company.
© 2026 Syntellia LLC. All rights reserved.
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. It also provides commercial health insurance services; capital resources; and various management services, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
Rule-based from financial data. Not advice.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 5 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $17.4B | $2.7B | $1.5B | $825M | 20.5% | 9.7% | 30.4% |
| 2024 | $15.8B | $2.3B | $1.1B | $1.1B | 17.1% | 10.8% | 59.1% |
| 2023 | $14.3B | $1.7B | $718M | $525M | 11.7% | 6.6% | 6.2% |
| 2022 | $13.4B | $1.6B | $676M | $262M | 11.4% | - | - |
| 2021 |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2025 |
|---|---|
| Total Revenue | 17,364.83 |
| Operating Revenue | 17,364.83 |
| Cost Of Revenue | 1,659.01 |
| Gross Profit | 15,705.82 |
| Operating Expense | 13,711.80 |
| Selling General And Administration | 8,232.82 |
| Total Expenses | 15,370.81 |
| Operating Income | 1,994.02 |
| Total Operating Income As Reported | 1,994.02 |
| EBITDA | 2,743.14 |
| Normalized EBITDA | 2,743.14 |
| EBIT | 2,124.40 |
| Interest Income | 1.19 |
| Interest Expense | 152.26 |
| Net Interest Income | -156.07 |
| Other Non Operating Income Expenses | 134.19 |
| Other Income Expense | 134.19 |
| Interest Income Non Operating | 1.19 |
| Interest Expense Non Operating | 152.26 |
| Net Non Operating Interest Income Expense | -156.07 |
| Pretax Income | 1,972.14 |
| Tax Provision | 460.96 |
| Tax Rate For Calcs | 0 |
| Tax Effect Of Unusual Items | 0 |
| Net Income Continuous Operations | 1,511.18 |
| Net Income From Continuing And Discontinued Operation | 1,488.80 |
| Net Income From Continuing Operation Net Minority Interest | 1,488.80 |
| Net Income | 1,488.80 |
| Net Income Common Stockholders | 1,488.80 |
| Net Income Including Noncontrolling Interests | 1,511.18 |
| Normalized Income | 1,488.80 |
| Diluted NI Availto Com Stockholders | 1,488.80 |
| Basic Average Shares | 63.58 |
| Diluted Average Shares | 64.46 |
| Reconciled Depreciation | 618.74 |
| Reconciled Cost Of Revenue | 1,659.01 |
| Minority Interests | -22.39 |
| Depreciation Amortization Depletion Income Statement | 618.74 |
| Depreciation And Amortization In Income Statement | 618.74 |
| General And Administrative Expense | 8,232.82 |
| Salaries And Wages | 8,084.58 |
| Rent Expense Supplemental | 148.23 |
| Total Other Finance Cost | 5 |
| Other Operating Expenses | 4,860.25 |
| Rent And Landing Fees | 148.23 |
| Otherunder Preferred Stock Dividend | 0 |
Healthcare sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| Universal Health Services, Inc.this co. | UHS | $8.6B | 5.80↓ discount | 1.19 | 20.5% | 4.98 |
| Incyte Corporation | INCY | $20.2B | 15.72 | 3.91 | 24.9% | 9.75 |
| Viatris Inc. | VTRS | $18.5B | - | 1.26 | -23.9% | - |
| Zimmer Biomet Holdings, Inc. | ZBH | $16.8B | 23.79 | 1.32 | 5.6% | 10.69 |
| Solventum Corporation | SOLV |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| $14.3B |
| 9.17 |
| 2.83 |
| 30.8% |
| 7.23 |
| DaVita Inc. | DVA | $12.3B | 16.52 | -18.94 | -114.7% | 9.29 |
| The Cooper Companies, Inc. | COO | $12.1B | 32.28 | 1.47 | 4.6% | 13.89 |
| Align Technology, Inc. | ALGN | $12.1B | 29.37 | 2.98 | 10.1% | 13.46 |
| Insulet Corporation | PODD | $10.1B | 41.04 | 6.69 | 16.3% | 21.20 |
| Peer Median | - | 23.79 | 2.15 | 7.8% | 10.69 | |